Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With VerapamilSR/ Trandolapril Fixed Combination (Tarka®) in Patients With Essential Hypertension in Routine Clinical Practice

NCT01127139 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01127139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01127139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With VerapamilSR/ Trandolapril Fixed Combination (Tarka®) in Patients With Essential Hypertension in Routine Clinical Practice
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
March 31, 2011
Enrollment
3,828 (actual)
Sites
134

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension